1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,053 | 0,095 | 02.04. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 26.03. | hVIVO PLC - Holding(s) in Company | - | RNS | ||
| 23.02. | hVIVO PLC - Issue of Equity and Total Voting Rights | - | RNS | ||
| 29.01. | hVIVO PLC - Trading Update | - | RNS | ||
| 27.01. | hVIVO PLC - Notice of Trading Update | - | RNS | ||
| 18.12.25 | hVIVO PLC - Appointment of Non-Executive Director | - | RNS | ||
| 15.12.25 | hVIVO PLC - CEO & CFO Share Purchase | - | RNS | ||
| 12.12.25 | Broker tips: Hvivo, Whitbread, IHG | 3 | Sharecast | ||
| 12.12.25 | Shore Capital hails improved US biotech funding environment for hVIVO | 1 | Sharecast | ||
| HVIVO Aktie jetzt für 0€ handeln | |||||
| 27.11.25 | Hvivo client acquired by MSD in $9.2bn deal | 8 | Sharecast | ||
| 27.11.25 | hVIVO PLC - MSD to acquire Cidara | 24 | RNS | ||
| 20.11.25 | hVIVO PLC - >£5 million CRS contracts signed | - | RNS | ||
| 11.11.25 | hVIVO develops three new human challenge models for viral testing | 3 | Investing.com | ||
| 11.11.25 | hVIVO meldet erfolgreiche Entwicklung von drei neuen humanen Challenge-Modellen | 1 | Investing.com Deutsch | ||
| 11.11.25 | hVIVO PLC - Positive data from novel human challenge models | - | RNS | ||
| 03.11.25 | hVIVO PLC - Presentation at Jefferies Healthcare Conference | - | RNS |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NUGEN MEDICAL DEVICES | 0,013 | +1,54 % | NuGen Medical Devices Inc.: NuGen Files Patent for Ready-to-Fill COP/COC Needle-Free Injection Nozzle, Advancing Prefilled Nozzle Technology | Toronto, Ontario--(Newsfile Corp. - March 25, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"), a leader in needle-free drug delivery, today announced the filing of a new patent covering... ► Artikel lesen | |
| PLUS THERAPEUTICS | 3,570 | +0,28 % | XFRA ISIN CHANGE | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenUS72941H5090 Plus Therapeutics Inc. 01.04.2026 US72941H8060 Plus Therapeutics Inc. 02.04.2026 Tausch 25:1XS2901882618 Leverage... ► Artikel lesen | |
| UNIDOC HEALTH | 0,060 | +11,09 % | UniDoc stellt Installation des H3 Health Cube in Italien fertig | - Der KI-gestützte Health Cube steht
ab sofort den Patienten im Dorf Guardia Perticara in der italienischen Region Basilikata zur Verfügung.
VANCOUVER, British Columbia... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,042 | -13,58 % | Mountain Valley MD Holdings Inc: Mountain Valley arranges offering, two debt settlements | ||
| ASENSUS SURGICAL | - | - | GlobalLogic, Asensus ink surgical robotics engineering collab | ||
| JD HEALTH INTERNATIONAL | 5,300 | -3,64 % | JD Health Grants 0.8344 Million Award Shares | ||
| LIFEWARD | 6,850 | -0,15 % | Lifeward Ltd.: Lifeward Successfully Closes on Strategic Partnership with Oramed | HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 25, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform... ► Artikel lesen | |
| LIGHT AI | 0,048 | +5,26 % | Light AI Inc. reports FY results | ||
| EKSO BIONICS | 9,310 | -13,88 % | Applied Digital Corporation: Applied Digital to Spin Out Cloud Business, Proposes Business Combination with EKSO to Launch ChronoScale | DALLAS, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Applied Digital (NASDAQ: APLD), a designer, builder, and operator of high-performance, sustainably engineered data centers and colocation services for artificial... ► Artikel lesen | |
| IMUNON | 2,660 | 0,00 % | Imunon, Inc.: IMUNON Reports 2025 Financial Results and Provides Business Update Highlighting Significant Progress with Pivotal Phase 3 Study | IMNN-001 is the first frontline immunotherapy to demonstrate the potential for a clinically meaningful overall survival benefit in women newly diagnosed with advanced ovarian cancer Final Phase 2... ► Artikel lesen | |
| GLOBAL HEMP GROUP | 0,014 | -100,00 % | Global Hemp Group Inc.: Global Hemp Group Applies for Partial Revocation Order and Announces Proposed Financing | Vancouver, British Columbia--(Newsfile Corp. - October 9, 2025) - Global Hemp Group Inc. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG0) ("GHG" or the "Company") announces that it has applied to the British... ► Artikel lesen | |
| ROCKWELL MEDICAL | 0,788 | +3,35 % | H.C. Wainwright cuts Rockwell Medical stock price target to $2 on sales miss | ||
| AROVELLA THERAPEUTICS | 0,040 | -2,44 % | AROVELLA THERAPEUTICS LIMITED: CLDN18.2 CAR iNKT Cell Preclinical Data Update | ||
| MEMPHASYS | 0,001 | 0,00 % | MEMPHASYS LIMITED: Memphasys Investor Webinar | ||
| PREVECEUTICAL MEDICAL | 0,008 | 0,00 % | PreveCeutical Medical Inc.: PreveCeutical Adopts Semi-Annual Financial Reporting | Vancouver, British Columbia--(Newsfile Corp. - April 1, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCID: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical") announces that it has elected... ► Artikel lesen |
Das Unternehmen HVIVO PLC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,081 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu HVIVO PLC finden Sie auf Wallstreet Online.